Enricoso, Bb Boy .
HRN: 21-26-28 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/30/2022
05/07/2022
IV
15 Mg
Q36h
Neonatal Sepsis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes